Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases

European Urology

Volumn 60, Issue 1, 2011, Pages 125-130

  Budiharto, Tom ^a   Joniau, Steven ^a   Lerut, Evelyne ^a   Van Den Bergh, Laura ^a   Mottaghy, Felix ^b   Deroose, Christophe M ^b   Oyen, Raymond ^a   Ameye, Filip ^a   Bogaerts, Kris ^c   Haustermans, Karin ^a   Van Poppel, Hendrik ^a  

^a UH Leuven   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c KU LEUVEN   (Belgium)

Author keywords

C11 choline PET CT; Diffusion weighted MRI; High risk; Imaging; Lymph node staging; Prostate cancer

Indexed keywords

CHOLINE C 11; IOPROMIDE; CARBON; CHOLINE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RISK FACTOR;

ADENOCARCINOMA; AGED; CARBON RADIOISOTOPES; CHOLINE; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957959529     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.01.015     Document Type: Article

References (18)

1. D.V. Makarov, B.J. Trock, and E.B. Humphreys Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 Urology 69 2007 1095 1101 (Pubitemid 46891611)
2. A. Heidenreich, Z. Varga, and R. Von Knobloch Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis J Urol 167 2002 1681 1686 (Pubitemid 34240702)
3. M.C. Schumacher, F.C. Burkhard, G.N. Thalmann, A. Fleischmann, and U.E. Studer Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy Eur Urol 54 2008 344 352
4. J.A. Petros, and W.J. Catalona Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer J Urol 147 1992 1574 1575
5. M.H. Han, A.W. Partin, and C.R. Pound Long term biochemical disease-free and cancer-specific survival following anatomical radical retropubic prostatectomy: the 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555 565 (Pubitemid 32916759)
6. S. Joniau, C.-Y. Hsu, and E. Lerut A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer Eur Urol 51 2007 388 396 (Pubitemid 44937792)
7. Ries LA, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973-99. Bethesda, MD: National Cancer Institute; 2002.
8. A. Briganti, F.K.-H. Chun, and A. Salonia Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy Eur Urol 49 2006 1019 1027 (Pubitemid 43674000)
9. A.M. Hövels, R.A. Heesakkers, and E.M. Adang The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin Radiol 63 2008 387 395
10. R.H. Oyen, H.P. Van Poppel, F.E. Ameye, W.A. Van de Voorde, A.L. Baert, and L.V. Baert Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients Radiology 190 1994 315 322 (Pubitemid 24044226)
11. T. Clark, D.J. Parekh, and M.S. Cookson Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer J Urol 169 2003 145 147 (Pubitemid 35461573)
12. I.J. de Jong, J. Pruim, P.H. Elsinga, W. Vaalburg, and H.J. Mensink Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET J Nucl Med 44 2003 331 335 (Pubitemid 39586006)
13. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms Eur Urol 54 2008 392 401
14. M. Eiber, A.J. Beer, and K. Holzapfel Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging Invest Radiol 45 2010 15 23
15. 11C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer Mol Imaging Biol 13 2011 352 361
16. 11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429 (Pubitemid 46963456)
17. V. Vandecaveye, F. De Keyzer, and V. Vander Poorten Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging Radiology 251 2009 134 146
18. R. Heesakkers, A. Hovels, and G. Jager MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study Lancet Oncol 9 2008 850 856